home / stock / cntb / cntb news


CNTB News and Press, Connect Biopharma Holdings Limited

Stock Information

Company Name: Connect Biopharma Holdings Limited
Stock Symbol: CNTB
Market: NASDAQ
Website: connectbiopharm.com

Menu

CNTB CNTB Quote CNTB Short CNTB News CNTB Articles CNTB Message Board
Get CNTB Alerts

News, Short Squeeze, Breakout and More Instantly...

CNTB - Most and least shorted healthcare stocks with up to $2B market cap in February

2026-03-03 09:35:51 ET More on Short interest: Hims & Hers short interest climbs amid legal risk related to weight loss pill... Michael Saylor’s Strategy tops U.S. short list, but high short interest may not signal...

CNTB - Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference

SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory d...

CNTB - Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory di...

CNTB - Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026

– Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart – – Recruitment ongoing for Phase 1b study of intravenously-administered rademikibart designed to further confirm its unique ability to rapidly improve a...

CNTB - CNTB Price Target Alert: $9.00. Issued by Lake Street

2025-12-01 09:06:38 ET Thomas Flaten from Lake Street issued a price target of $9.00 for CNTB on 2025-12-01 13:40:16. The adjusted price target was set to $9.00. At the time of the announcement, CNTB was trading at $2.86. The overall price target consensus is at $1.50 wi...

CNTB - Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference

SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory di...

CNTB - US Companies Moving the Markets, Morning edition
Mon, Nov 17, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States UTime Limited (WTO) rose 19.5% to $0.0239 on volume of 1,443,045,697 shares Aspire Biopharma Holdings Inc. (ASBP) rose 1.0% to $0.1063 on volume of 546,877,189 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.8% to $3.86...

CNTB - Connect Biopharma GAAP EPS of -$0.31

2025-11-12 10:40:39 ET More on Connect Biopharma Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript Seeking Alpha’s Quant Rating on Connect Biopharma ...

CNTB - Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update

– Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in 1H26 – – New Drug Application for rademikibart for the treatment of atopic dermatitis submitted by Simcere, the Comp...

CNTB - Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript

2025-11-03 21:36:24 ET Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases November 3, 2025 4:15 PM EST... Read the full article on Seeking Alpha For further details see: Conne...

Next 10